AAAAAA
Results:
1-11
|
Results: 11
Authors:
SCHWARTZ GN
LIU YQ
TISDALE J
WALSHE K
FOWLER D
GRESS R
BERGAN RC
Citation: Gn. Schwartz et al., GROWTH-INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS BY ODN-1, AN APTAMERIC INHIBITOR OF P210(BCR-ABL) TYROSINE KINASE-ACTIVITY, Antisense & nucleic acid drug development, 8(4), 1998, pp. 329-339
Authors:
THIBAULT A
FIGG WD
BERGAN RC
LUSH RM
MYERS CE
TOMPKINS A
REED E
SAMID D
Citation: A. Thibault et al., A PHASE-II STUDY OF 5-AZA-2'DEOXYCYTIDINE (DECITABINE) IN HORMONE-INDEPENDENT METASTATIC (D2) PROSTATE-CANCER, Tumori, 84(1), 1998, pp. 87-89
Authors:
ROHLFF C
BLAGOSKLONNY MV
KYLE E
KESARI A
KIM IY
ZELNER DJ
HAKIM F
TREPEL J
BERGAN RC
Citation: C. Rohlff et al., PROSTATE-CANCER CELL-GROWTH INHIBITION BY TAMOXIFEN IS ASSOCIATED WITH INHIBITION OF PROTEIN-KINASE-C AND INDUCTION OF P21(WAF1 CIP1)/, The Prostate, 37(1), 1998, pp. 51-59
Authors:
BERGAN RC
Citation: Rc. Bergan, EX-VIVO BONE-MARROW PURGING WITH OLIGONUCLEOTIDES, ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 7(3), 1997, pp. 251-255
Authors:
DAWSON NA
FIGG WD
COOPER MR
SARTOR O
BERGAN RC
SENDEROWICZ AM
STEINBERG SM
TOMPKINS A
WEINBERGER B
SAUSVILLE EA
REED E
MYERS CE
Citation: Na. Dawson et al., PHASE-II TRIAL OF SURAMIN, LEUPROLIDE, AND FLUTAMIDE IN PREVIOUSLY UNTREATED METASTATIC PROSTATE-CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1470-1477
Authors:
BERGAN RC
WALLS RG
FIGG WD
DAWSON NA
HEADLEE D
TOMPKINS A
STEINBERG SM
REED E
Citation: Rc. Bergan et al., SIMILAR CLINICAL OUTCOMES IN AFRICAN-AMERICAN AND NON-AFRICAN-AMERICAN MALES TREATED WITH SURAMIN FOR METASTATIC PROSTATE-CANCER, Journal of the National Medical Association, 89(9), 1997, pp. 622-628
Authors:
BERGAN RC
KYLE E
CONNELL Y
NECKERS L
Citation: Rc. Bergan et al., INHIBITION OF PROTEIN-TYROSINE KINASE-ACTIVITY IN INTACT-CELLS BY THEAPTAMERIC ACTION OF OLIGODEOXYNUCLEOTIDES, Antisense research and development, 5(1), 1995, pp. 33-38
Authors:
DAWSON NA
COOPER MR
FIGG WD
HEADLEE DJ
THIBAULT A
BERGAN RC
STEINBERG SM
SAUSVILLE EA
MYERS CE
SARTOR O
Citation: Na. Dawson et al., ANTITUMOR-ACTIVITY OF SURAMIN IN HORMONE-REFRACTORY PROSTATE-CANCER CONTROLLING FOR HYDROCORTISONE TREATMENT AND FLUTAMIDE WITHDRAWAL AS POTENTIALLY CONFOUNDING VARIABLES, Cancer, 76(3), 1995, pp. 453-462
Authors:
FIGG WD
SARTOR O
COOPER MR
THIBAULT A
BERGAN RC
DAWSON N
REED E
MYERS CE
Citation: Wd. Figg et al., PROSTATE-SPECIFIC ANTIGEN DECLINE FOLLOWING THE DISCONTINUATION OF FLUTAMIDE IN PATIENTS WITH STAGE D2 PROSTATE-CANCER, The American journal of medicine, 98(4), 1995, pp. 412-414
Authors:
BERGAN RC
KYLE E
NECKERS L
Citation: Rc. Bergan et al., GENISTEIN - A PROTEIN-TYROSINE KINASE INHIBITOR INHIBITS THE GROWTH OF PROSTATE-CANCER CELLS, Journal of cellular biochemistry, 1994, pp. 251-251
Authors:
BERGAN RC
CONNEL Y
FAHMY B
KYLE E
NECKERS L
Citation: Rc. Bergan et al., SYNTHETIC OLIGONUCLEOTIDES - POTENT APTAMERIC INHIBITORS OF PROTEIN TYROSINE KINASES, Journal of cellular biochemistry, 1993, pp. 210-210
Risultati:
1-11
|